
Arjun Deb MD
Associate Professor, Medicine, University of California, Los Angeles
Join to View Full Profile
10833 LeConte Ave., A2-237 CHSLos Angeles, CA 90095
Phone+1 310-825-5280
Fax+1 310-825-5280
Dr. Deb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2002 - 2005
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1999 - 2002
- Medical College and Hospital KolkataClass of 1997
Certifications & Licensure
- CA State Medical License 2013 - 2026
- NC State Medical License 2005 - 2016
- MN State Medical License 2001 - 2013
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- Label-free optical mapping for large-area biomechanical dynamics of multicellular systems.Yen-Ju Lin, Xing Haw Marvin Tan, Yijie Wang, Pei-Shan Chung, Xiang Zhang
Biosensors & Bioelectronics. 2025-06-01 - Collagen V regulates renal function after kidney injury and can be pharmacologically targeted to enhance kidney repair in mice.Lianjiu Su, Qihao Sun, Yusheng Li, Juan Felipe Alvarez, Bo Tao
Science Translational Medicine. 2025-04-09 - 3 citationsA humanized monoclonal antibody targeting an ectonucleotidase rescues cardiac metabolism and heart function after myocardial infarction.Shen Li, Bo Tao, Jijun Wan, Enca Montecino-Rodriguez, Ping Wang
Cell Reports. Medicine. 2024-11-19
Press Mentions
- UCLA Researchers Unveil Precision Medicine Strategy to Prevent Kidney FailureApril 9th, 2025
- UCLA Study Identifies Key Protein Driving Kidney ScarringApril 8th, 2025
- First-of-Its-Kind Experimental Therapy Enhances Tissue Repair After Heart AttackOctober 29th, 2024
- Join now to see all
Grant Support
- Role of macrophages in regulating cardiac muscle metabolismUNIVERSITY OF CALIFORNIA LOS ANGELES2025–2028
- Adenine metabolism in cardiac repairUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2028
- Adenine metabolism in cardiac repairUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2028
- Adenine metabolism in cardiac repairUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2028
- Adenine metabolism in cardiac repairUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2028
- Adenine metabolism in cardiac repairUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2028
- Adenine metabolism in cardiac repairUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2028
- Adenine metabolism in cardiac repairUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2028
- Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failureUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failureUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failureUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failureUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failureUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failureUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failureUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicityUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
- Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicityUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
- Role of GPNMB in cardiac remodelingUNIVERSITY OF CALIFORNIA LOS ANGELES2020–2025
- Role of collagen heterogeneity in remodeling of acute and chronic heart scarsUNIVERSITY OF CALIFORNIA LOS ANGELES2020–2025
- Targeting cardiac fibroblast-myocyte cross talk to enhance heart function after cardiac injuryUNIVERSITY OF CALIFORNIA LOS ANGELES2020–2025
- Targeting cardiac fibroblast-myocyte cross talk to enhance heart function after cardiac injuryUNIVERSITY OF CALIFORNIA LOS ANGELES2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: